Molecular Imaging 2017

A Cost-Effective Tool

 Comparison of 10-12 core TRUSGB to mpMRI & mRI guided biopsy  Comparable costs but with higher QoL  Expected costs per patient: 2423 euros (MRI) vs 2392 (TRUS-GB)  Corresponding QALYs (quality adjusted life years) higher for MRI strategy : incremental cost-effectiveness ratio of 323 euros per QALY

Rooij et al. Eur Urol 2014; 66 (2014) 430–436